Swiss pharmaceutical company Vifor Pharma’s shares soared 15% on Dec. 2 following a report in The Australian newspaper that Melbourne-based biotechnology group CSL was in talks regarding a possible takeover worth $7 billion.
- Zurich-based Vifor specialises in treatments for iron deficiencies, while $99 billion CSL develops biotherapies and influenza vaccines.
- CSL and Vifor both said on Dec. 2 they do not speculate on market rumours.
***
for this reason AUD is down when you have this size of transaction $7 billion will effect the value of currency ,even if it speculation .
29/11 Week, page-457
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add XJO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7,959.3 |
Change
69.700(0.88%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 7,889.6 | 7,969.1 | 7,889.0 |
| XJO (ASX) Chart |